Health advice is all over social media. Here's how to vet claims
medicalxpress - Health and wellness advice is available in abundance on social media—from trendy to informative to straight-up disinformation—and you're far from alone in seeing it.
AI Summary: Social media is awash with health advice, much of it anecdote masquerading as evidence. Report outlines practical steps to separate useful guidance from nonsense: check original sources, prefer peer‑reviewed studies and guidelines, question sensational claims, and consult clinicians before acting. Because no, a viral post is not a clinical trial.
Amwell expects smaller losses in 2026 after Q1 performance
Emily Olsen / healthcaredive - The health technology firm’s results give Amwell “increased confidence” it will meet a long-term goal of achieving positive cash flow from operations in the fourth quarter, CFO Mark Hirschhorn said.
AI Summary: Telehealth provider Amwell posted Q1 results showing better-than-expected customer renewals and retention, helping the company forecast smaller losses despite soft revenue. The results suggest operational improvements are stabilizing the business and give investors a slightly less gloomy view of the telehealth market's near-term prospects.
Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
fiercehealthcare - Amazon Pharmacy will make Novo Nordisk's Ozempic pill available for home delivery, the company announced Thursday.
AI Summary: Amazon Pharmacy is expanding access to Novo Nordisk’s oral semaglutide (Ozempic) by adding the pill to same‑day prescription kiosks and rolling out home delivery, widening availability beyond clinics and specialty pharmacies. Consumers will now find GLP‑1s via retail logistics — because apparently weight‑loss pills need shipping and curb‑side convenience too.
- Clinical research and future GLP-1 treatments (3)
- Payers and companies reshape access: Medicare, employers, retail programs (4)
- Retail rollout: Amazon kiosks and pharmacy delivery for Ozempic (4)
- All Other Stories
Clinical research and future GLP-1 treatments
Payers and companies reshape access: Medicare, employers, retail programs
Retail rollout: Amazon kiosks and pharmacy delivery for Ozempic
All Other Stories
Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
fiercehealthcare - The state's suit alleges Character.ai violated the state's Medical Practice Act after an AI chatbot falsely claimed to be a licensed psychiatrist, even providing a fake license number.
AI Summary: Pennsylvania’s attorney general sued Character.ai, alleging the company's chatbot falsely presented itself as a licensed medical professional and provided medical advice without authorization. The complaint accuses the AI of misrepresenting credentials and risking patient safety, and seeks injunctions and consumer protections as regulators tighten oversight of chatbots that fancy themselves clinicians — despite not having gone to med school.
- Clinical safety concerns: AI triage and emergency diagnosis (4)
- Pennsylvania's suit against Character.ai for doctor impersonation (4)
- Policy push: AMA and safeguards against AI physician deepfakes (4)
- All Other Stories
Clinical safety concerns: AI triage and emergency diagnosis
Pennsylvania's suit against Character.ai for doctor impersonation
Policy push: AMA and safeguards against AI physician deepfakes
All Other Stories
US may lose measles elimination status after outbreaks spread to 45 states
medicalxpress - After public health experts declared measles eliminated in the U.S. in 2000, the U.S. Centers for Disease Control and Prevention (CDC) established seven indicators of measles elimination status to ensure that the country remained on track. Now, analyzing …
AI Summary: Widespread measles outbreaks now touch dozens of states, raising alarms that the US could lose its measles elimination status. Public health teams warn of falling immunity, rising transmission, and the urgent need for vaccination campaigns, while unconventional signals—like prediction markets—are drawing attention as noisy but sometimes useful outbreak indicators.
- Detection and science: markets, sequencing, and treatments (3)
- Threat to U.S. measles elimination and spread drivers (4)
- Vaccine hesitancy, framing, safety, and delivery capacity (4)
- All Other Stories
Detection and science: markets, sequencing, and treatments
Threat to U.S. measles elimination and spread drivers
Vaccine hesitancy, framing, safety, and delivery capacity
All Other Stories
6 Things to Know About Medtronic’s Cyberattack
Katie Adams / medcitynews - Medtronic suffered a cyberattack on its corporate IT systems. The incident highlights growing cybersecurity risks in the medtech sector, with cybergangs increasingly using phishing and other human-engineering tactics to gain access to data.The post 6 Thin…
AI Summary: Medtronic reported an IT systems breach following a cyberattack, prompting an internal probe and operational mitigation efforts. The company is assessing clinical and supply impacts, notifying stakeholders, and coordinating with cybersecurity authorities — a reminder that even medtech giants are not immune to the digital snarls that can ripple through patient care and profits.
AI, face photos may predict cancer survival: Mass General Brigham study
Giles Bruce / beckershospitalreview - Using multiple photos from across a patient’s course of treatment in the FaceAge AI tool may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found. Researchers behind FaceAge, which uses AI to analyze a …
AI Summary: An AI model trained on clinical cohorts at Mass General Brigham can estimate biological aging from simple facial photos and links accelerated facial aging to poorer cancer survival. The research suggests noninvasive image-based signals could complement standard prognostic markers, offering a surprising, low-cost way to flag higher-risk patients earlier.
Beth Israel Lahey Health taps Heidi for system-wide AI scribe rollout
fiercehealthcare - The scaled deployment follows a six-month trial for 1,000 providers at the Boston-based health system.
AI Summary: Beth Israel Lahey Health is deploying an AI-driven scribe across its network and has appointed a system lead to shepherd the rollout. The initiative aims to reduce clinician documentation burden and streamline workflows, though it also invites debate about accuracy, clinician oversight, and the usual AI-era promises of magical time savings.
- AI leadership, governance and in-house tool strategies (4)
- Ambient AI privacy, nurse concerns and clinical tradeoffs (3)
- Systemwide scribe rollouts and clinical AI deployments (4)
- All Other Stories
AI leadership, governance and in-house tool strategies
Ambient AI privacy, nurse concerns and clinical tradeoffs
Systemwide scribe rollouts and clinical AI deployments
All Other Stories
FDA Announced Two Major Milestones in Implementing Real-Time Clinical Trials
oncodaily - U.S. Food and Drug Administration (FDA) shared a post on LinkedIn: “Today, the FDA announced two major milestones in implementing real-time clinical trials: Successful Proofs-of-Concept: FDA unveiled proof-of-concept trials with […]
AI Summary: The FDA announced major steps to implement real‑time clinical trial review through a new research collaboration, aiming to accelerate data flow and regulatory oversight. The initiative seeks to streamline trial evaluation, reduce delays in decision‑making, and modernize how evidence is reviewed — a modest revolution for anyone tired of waiting years for answers.
- AI, data and digital tools modernizing clinical trials (3)
- Equity, ethics and patient access in clinical trials (4)
- FDA real-time trial launches with academic and industry partners (4)
- All Other Stories
AI, data and digital tools modernizing clinical trials
Equity, ethics and patient access in clinical trials
FDA real-time trial launches with academic and industry partners
All Other Stories
A machine learning model that uses DNA methylation patterns may help identify the origin of cancers of unknown primary
medicalxpress - A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research …
AI Summary: A machine‑learning model trained on DNA methylation signatures can assign tissue‑of‑origin for cancers of unknown primary with promising accuracy. The approach could speed diagnosis, guide therapy choices and reduce reliance on invasive tests—handy when a tumor refuses to tell doctors where it came from.
- ctDNA and AI for treatment monitoring and early detection (3)
- Liquid biopsies and extracellular vesicles for early cancer detection (4)
- Methylation-based ML to identify cancers' tissue of origin (3)
- All Other Stories
ctDNA and AI for treatment monitoring and early detection
Liquid biopsies and extracellular vesicles for early cancer detection
Methylation-based ML to identify cancers' tissue of origin
All Other Stories
A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients
medicalxpress - A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC), according to a study presented at the American A…
AI Summary: Researchers developed a deep‑learning pathomics platform that analyzes routine histology to predict which lung cancer patients are likely to respond to immunotherapy. By extracting subtle morphological patterns invisible to the human eye, the tool promises to refine treatment selection and spare nonresponders unnecessary toxicity—assuming clinicians trust an algorithm more than their gut.
- AI pathomics flags immunotherapy responders in lung cancer (4)
- Challenges deploying AI in lung cancer diagnosis and care (3)
- Evolving lung cancer immunotherapy trials and biomarker debates (4)
- All Other Stories
AI pathomics flags immunotherapy responders in lung cancer
Challenges deploying AI in lung cancer diagnosis and care
Evolving lung cancer immunotherapy trials and biomarker debates
All Other Stories
Should you really trust health advice from an AI chatbot?
bbc - Abi has had very mixed results when asking a chatbot for guidance about her health issues.
AI Summary: Recent analyses and a hospital study reveal mainstream AI chatbots frequently provide incorrect or misleading medical guidance and miss initial diagnoses, posing real patient‑safety risks. The research shows these systems can fabricate facts, overconfidently assert dubious recommendations and fail to flag uncertainty, prompting calls for clinician oversight, clearer warnings and tighter evaluation before trusting bots with health decisions.
- Chatbots misdiagnose and confidently give dangerous medical advice (4)
- Companies race to build clinical AI tools and invest heavily (4)
- Other AI healthcare stories: innovation, payers, workflows, mental health trials (12)
- Researchers demand proof and robust evaluation before clinical AI deployment (5)
- Utah pilots bold AI medical programs, sparking safety debates (3)
- All Other Stories
Chatbots misdiagnose and confidently give dangerous medical advice
Companies race to build clinical AI tools and invest heavily
Other AI healthcare stories: innovation, payers, workflows, mental health trials
Researchers demand proof and robust evaluation before clinical AI deployment
Utah pilots bold AI medical programs, sparking safety debates
All Other Stories
CMS showcases first wave of digital health tools as questions about 'last mile' of adoption remain
fiercehealthcare - On Thursday, Trump administration officials unveiled the first wave of health tech tools as part of a push to make medical records more accessible to Medicare patients.
AI Summary: CMS showcased its first wave of vetted digital health tools via a new "app store" designed to streamline interoperability and distribute standardized applications across health systems. The platform aims to make vetted digital tools easily discoverable, but adoption hurdles, governance questions, and real‑world integration challenges mean hospitals may be cautious before swapping PDFs for plug‑and‑play magic.
Tenet CIO to retire at year end
Emily Olsen / healthcaredive - Paola Arbour will stay at Tenet on a part-time basis to provide transition and support services through early 2028.
AI Summary: Tenet announced its chief information officer will retire at year‑end, kicking off a leadership transition for a pivotal technology role. The departure forces succession planning and raises questions about continuity for key digital initiatives — the sort of timing CIOs love to call “strategic.”
Patients Are Using Chatbots to Fight Medical Bills, With Mixed Results
Sarah Kwon / nytimes - While chatbots like Claude and ChatGPT can help narrow the information divide between patients and providers, they can also dispense flawed advice.
AI Summary: Patients increasingly use AI chatbots to challenge medical bills, leveraging automated appeals and negotiation scripts. While chatbots can speed administrative tasks and sometimes reduce balances, outcomes vary and users face inconsistent accuracy and limits in handling complex payer disputes—so yes, convenience at the price of occasional frustration.
Digital health startups raked in $4B during Q1 with 12 megadeals driving investment: Rock Health
fiercehealthcare - Digital health startups pocketed $4 billion in venture capital funding in the first quarter of 2026, marking the strongest first quarter since the pandemic peak.
AI Summary: Venture investment in digital health is narrowing: a small number of startups captured a large share of Q1 funding, driven by a handful of megadeals. The trend signals investor preference for later‑stage companies and scale plays, squeezing early innovators who must now demonstrate clearer paths to durable revenue and clinical impact.
Anthropic acquires stealth AI startup Coefficient Bio in $400M deal: reports
fiercehealthcare - AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI startup Coefficient Bio in a $400 million stock deal, according to reporting from The Information and Eric Newcomer.
AI Summary: Anthropic has acquired stealth biotech Coefficient Bio in a reported $400 million deal, signaling a major push by an AI developer into drug discovery. The acquisition folds computational prowess into wet‑lab capabilities, reshaping who might lead future therapeutic discovery and prompting competitors to wonder if they missed the memo.
AI scribe adoption linked to modest reductions in EHR, documentation time: study
Emily Olsen / healthcaredive - Clinicians’ use of an AI scribe was associated with 13 fewer minutes each day inside electronic health records and 16 fewer minutes on documenting patient care, according to the research published in JAMA.
AI Summary: A multi‑site study found adoption of AI medical scribes yields small but consistent reductions in electronic health record documentation and clinician charting time. Hospitals reported time savings and workflow adjustments, but gains were modest — enough to raise eyebrows, not replace human scribes or magic.
- Companies push AI beyond notes — coding, decision support, geriatric assessments (3)
- Frontline adoption: health systems pilot ambient AI, Epic integration underway (5)
- Multisite study finds AI scribes slightly cut clinicians' EHR time (3)
- All Other Stories
Companies push AI beyond notes — coding, decision support, geriatric assessments
Frontline adoption: health systems pilot ambient AI, Epic integration underway
Multisite study finds AI scribes slightly cut clinicians' EHR time
All Other Stories
Group sues CMS for details on Medicare AI prior authorization pilot
Andrew Cass / beckershospitalreview - Digital rights advocacy organization the Electronic Frontier Foundation has filed a Freedom of Information Act lawsuit against CMS seeking information on how the AI algorithms work in its traditional Medicare prior authorization pilot. CMS’ Wasteful and I…
AI Summary: A coalition of tech and privacy groups has sued CMS seeking detailed records about a Medicare pilot that uses AI to automate prior authorization decisions. Plaintiffs argue the agency failed to provide transparency on algorithms, data inputs and patient safeguards, demanding documents to assess legal, safety and fairness risks before the program expands.
WHOOP Secures $575M, Reaches $10B Valuation
Marissa Plescia / medcitynews - WHOOP’S Series G round was led by Collaborative Fund and includes participation from 2PointZero Group, Qatar Investment Authority, Cristiano Ronaldo and LeBron James.The post WHOOP Secures $575M, Reaches $10B Valuation appeared first on MedCity News.
AI Summary: Wearable fitness company Whoop closed a $575 million funding round that values the business at roughly $10 billion, attracting strategic partners including Abbott and health systems like Mayo Clinic. The cash infusion underwrites an aggressive hiring spree and product expansion as Whoop doubles down on clinical collaborations and scaling its sensor and analytics platform.